Lisa Gallicchio

Biography

Dr. Lisa Gallicchio is a Program Director in the Epidemiology and Genomics Research Program's (EGRP) Clinical and Translational Epidemiology Branch (CTEB). She is involved in research efforts to identify clinical and genomic factors that influence cancer treatment outcomes, including those factors that may contribute to observed disparities in health outcomes. Prior to joining EGRP, Dr. Gallicchio was a Senior Epidemiologist in The Prevention and Research Center in the Weinberg Center for Women's Health & Medicine at Mercy Medical Center. During this time, she also served as an Adjunct Assistant Professor in the University of Maryland at Baltimore, Department of Epidemiology and Public Health and the Johns Hopkins University Bloomberg School of Public Health Department of Epidemiology. Dr. Gallicchio's work at Mercy Medical Center involved overseeing studies aimed at better understanding long-term health outcomes of cancer survivors as well as factors associated with cancer treatment adherence. She was the Principal Investigator of a cohort study examining racial differences in the cardiovascular health effects of aromatase inhibitors, a hormonal therapy commonly used among breast cancer patients. Dr. Gallicchio's research specialties also include clarifying factors that underlie the conditions affecting the health of women during midlife. She has a particular interest in health disparities.

Research Interest

Cancer survivorship; Cancer treatment toxicity and long-term health of cancer survivors; Patient reported outcomes; Health disparities; Medication adherence; Women's health